G-Protein–Coupled Receptors in Heart Disease

2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536 · see citing works

Heart disease and stroke statistics-2018 update: a report from the american heart association

Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146 · see citing works

The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure

Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649 · see citing works

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304 · see citing works

Crystal structure of the β2 adrenergic receptor–Gs protein complex

Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009 · see citing works

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735 · see citing works

Seven-transmembrane receptors

Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,712 · see citing works

The structure and function of G-protein-coupled receptors

Rosenbaum, D. M., Rasmussen, S. G. F., & Kobilka, B. K. (2009) · Nature · doi:10.1038/nature08144 · Cited by 2,534 · see citing works

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

Rajagopalan, S., Kurz, S. D., Münzel, T. F., Tarpey, M. M., Freeman, B. Α., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,441 · see citing works

Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations

Boudoulas, K. D., BORER, J. S., & Boudoulas, H. K. (2015) · Cardiology · doi:10.1159/000435947 · Cited by 1,952 · see citing works

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924 · see citing works

Regulation of cardiac hypertrophy by intracellular signalling pathways

Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,856 · see citing works

G proteins and dual control of adenylate cyclase

Gilman, A. G. (1984) · Cell · doi:10.1016/0092-8674(84)90336-2 · Cited by 1,812 · see citing works

Structural diversity of G protein-coupled receptors and significance for drug discovery

Lagerström, M. C., & Schiöth, H. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2518 · Cited by 1,489 · see citing works

β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes

Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S. R., Rocca, G. J. D., Lin, F., Kawakatsu, H., Owada, K. M., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,473 · see citing works

Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro

Sadoshima, J.-I., Xu, Y., Slayter, H. S., & Izumo, S. (1993) · Cell · doi:10.1016/0092-8674(93)90541-w · Cited by 1,348 · see citing works

Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A

Daaka, Y., Luttrell, L. M., & Lefkowitz, R. J. (1997) · Nature · doi:10.1038/36362 · Cited by 1,278 · see citing works

Muscarinic Receptors—Characterization, coupling and function

Caulfield, M. P. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90027-b · Cited by 1,277 · see citing works

The βγ subunits of GTP-binding proteins activate the muscarinic K+ channel in heart

Logothetis, D. E., Kurachi, Y., Galper, J., Neer, E. J., & Clapham, D. E. (1987) · Nature · doi:10.1038/325321a0 · Cited by 1,208 · see citing works

Heterotrimeric G protein activation by G-protein-coupled receptors

Oldham, W. M., & Hamm, H. E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2299 · Cited by 1,174 · see citing works

G-protein-coupled receptors and signaling networks: emerging paradigms

Marinissen, M. J., & Gutkind, J. S. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01678-3 · Cited by 1,049 · see citing works

An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior

Beaulieu, J., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980 · see citing works

Seven-transmembrane-spanning receptors and heart function

Rockman, H. A., Koch, W. J., & Lefkowitz, R. J. (2002) · Nature · doi:10.1038/415206a · Cited by 938 · see citing works

Regulation of protein kinase C

Newton, A. C. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80058-0 · Cited by 914 · see citing works

ECM remodeling in hypertensive heart disease

Berk, B. C., Fujiwara, K., & Lehoux, S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31044 · Cited by 898 · see citing works

p115 RhoGEF, a GTPase Activating Protein for Gα 12 and Gα 13

Kozasa, T., Jiang, X., Hart, M. J., Sternweis, P. M., Singer, W. D., Gilman, A. G., Bollag, G., & Sternweis, P. C. (1998) · Science · doi:10.1126/science.280.5372.2109 · Cited by 855 · see citing works

Direct activation of cardiac pacemaker channels by intracellular cyclic AMP

DiFrancesco, D., & Tortora, P. (1991) · Nature · doi:10.1038/351145a0 · Cited by 850 · see citing works

Teaching old receptors new tricks: biasing seven-transmembrane receptors

Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 826 · see citing works

Conformational biosensors reveal GPCR signalling from endosomes

Irannejad, R., Tomshine, J. C., Tomshine, J. R., Chevalier, M., Mahoney, J. P., Steyaert, J., Rasmussen, S. G. F., Sunahara, R. K., El-Samad, H., Huang, B., et al. (2013) · Nature · doi:10.1038/nature12000 · Cited by 819 · see citing works

Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser

Kang, Y., Zhou, X. E., Gao, X., He, Y., Liu, W., Ishchenko, A., Barty, A., White, T. A., Yefanov, O. M., Han, G. W., et al. (2015) · Nature · doi:10.1038/nature14656 · Cited by 804 · see citing works

The Dynamic Process of β2-Adrenergic Receptor Activation

Nygaard, R., Zou, Y., Dror, R. O., Mildorf, T. J., Arlow, D. H., Manglik, A., Pan, A. C., Liu, C. W., Fung, J. J., Bokoch, M. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.008 · Cited by 797 · see citing works

Progressive hypertrophy and heart failure in β 1 -adrenergic receptor transgenic mice

Engelhardt, S. H., Hein, L., Wiesmann, F., & Lohse, M. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7059 · Cited by 784 · see citing works

β-arrestin-mediated receptor trafficking and signal transduction

Shenoy, S. K., & Lefkowitz, R. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.05.002 · Cited by 714 · see citing works

Structural Features for Functional Selectivity at Serotonin Receptors

Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X., Vardy, E., McCorvy, J. D., Jiang, Y., Chu, M., Siu, F., et al. (2013) · Science · doi:10.1126/science.1232808 · Cited by 705 · see citing works

Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II

Zou, Y., Akazawa, H., Qin, Y., Sano, M., Takano, H., Minamino, T., Makita, N., Iwanaga, K., Zhu, W., Kudoh, S., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1137 · Cited by 685 · see citing works

Adrenergic and Muscarinic Receptors in the Human Heart

Brodde, O., & Michel, M. C. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01425-x · Cited by 673 · see citing works

Potential Therapeutic Targets for Cardiac Fibrosis

Leask, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.217737 · Cited by 661 · see citing works

Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.

Balligand, J., Kelly, R. A., Marsden, P. A., Smith, T. W., & Michel, T. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.347 · Cited by 659 · see citing works

Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility

Szokodi, I., Tavi, P., Földes, G., Voutilainen-Myllylä, S., Ilves, M., Tokola, H., Pikkarainen, S., Piuhola, J., Rysä, J., Tóth, M., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000033522.37861.69 · Cited by 625 · see citing works

Inhibition of myocardial endothelin pathway improves long-term survival in heart failure

Sakai, S., Miyauchi, T., Kobayashi, M., Yamaguchi, I., Goto, K., & Sugishita, Y. (1996) · Nature · doi:10.1038/384353a0 · Cited by 622 · see citing works

Adrenergic Nervous System in Heart Failure

Lymperopoulos, A., Rengo, G., & Koch, W. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.300308 · Cited by 608 · see citing works

β-Arrestin-biased ligands at seven-transmembrane receptors

Violin, J. D., & Lefkowitz, R. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.006 · Cited by 606 · see citing works

A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling

Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707936104 · Cited by 598 · see citing works

The selectivity of β‐adrenoceptor agonists at human β1‐, β2‐ and β3‐adrenoceptors

Baker, J. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00754.x · Cited by 591 · see citing works

The Role of the Funny Current in Pacemaker Activity

DiFrancesco, D. (2010) · Circulation Research · doi:10.1161/circresaha.109.208041 · Cited by 588 · see citing works

Pathophysiology of Heart Failure

Tanai, E., & Frantz, S. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140055 · Cited by 574 · see citing works

Association of β-Arrestin with G Protein-coupled Receptors during Clathrin-mediated Endocytosis Dictates the Profile of Receptor Resensitization

Oakley, R. H., Laporte, S. A., Holt, J. A., Barak, L. S., & Caron, M. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32248 · Cited by 567 · see citing works

GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling

Thomsen, A. R. B., Plouffe, B., Cahill, T. J., Shukla, A. K., Tarrasch, J. T., Dosey, A. M., Kahsai, A. W., Strachan, R. T., Pani, B., Mahoney, J. P., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.004 · Cited by 563 · see citing works

Opposing Effects of β1- and β2-Adrenergic Receptors on Cardiac Myocyte Apoptosis

Communal, C., Singh, K., Sawyer, D. B., & Colucci, W. S. (1999) · Circulation · doi:10.1161/01.cir.100.22.2210 · Cited by 562 · see citing works

The selectivity of β ‐adrenoceptor antagonists at the human β 1, β 2 and β 3 adrenoceptors

Baker, J. G. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706048 · Cited by 542 · see citing works

Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure

Adams, J. W., Sakata, Y., Davis, M. G., Sah, V. P., Wang, Y., Liggett, S. B., Chien, K. R., Brown, J. H., & Dorn, G. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10140 · Cited by 525 · see citing works

Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission

Hein, L., Altman, J. D., & Kobilka, B. K. (1999) · Nature · doi:10.1038/46040 · Cited by 518 · see citing works

Visualization of arrestin recruitment by a G-protein-coupled receptor

Shukla, A. K., Westfield, G., Xiao, K., Reis, R. I., Huang, L.-Y., Tripathi‐Shukla, P., Qian, J. X., Li, S., Blanc, A., Oleskie, A. N., et al. (2014) · Nature · doi:10.1038/nature13430 · Cited by 510 · see citing works

Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor

Ahn, S., Shenoy, S. K., Wei, H., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405878200 · Cited by 508 · see citing works

Targeting of Cyclic AMP Degradation to β 2 -Adrenergic Receptors by β-Arrestins

Perry, S. J., Baillie, G. S., Kohout, T. A., McPhee, I., Magiera, M. M., Ang, K. L., Miller, W. E., McLean, A. J., Conti, M., Houslay, M. D., et al. (2002) · Science · doi:10.1126/science.1074683 · Cited by 506 · see citing works

Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide

Shukla, A. K., Manglik, A., Kruse, A. C., Xiao, K., Reis, R. I., Tseng, W.-C., Staus, D. P., Hilger, D., Uysal, S., Huang, L.-Y., et al. (2013) · Nature · doi:10.1038/nature12120 · Cited by 470 · see citing works

Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature

Cat, A. N. D., Montezano, A. C. I., Burger, D. E., & Touyz, R. M. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4641 · Cited by 469 · see citing works

Cardiovascular Regulation in Mice Lacking α 2 -Adrenergic Receptor Subtypes b and c

Link, R. E., Desai, K. H., Hein, L., Stevens, M. E., Chruscinski, A. J., Bernstein, D., Barsh, G. S., & Kobilka, B. K. (1996) · Science · doi:10.1126/science.273.5276.803 · Cited by 468 · see citing works

Phase-plate cryo-EM structure of a class B GPCR–G-protein complex

Liang, Y.-L., Khoshouei, M., Radjainia, M., Zhang, Y., Glukhova, A., Tarrasch, J. T., Thal, D. M., Furness, S. G. B., Christopoulos, G., Coudrat, T., et al. (2017) · Nature · doi:10.1038/nature22327 · Cited by 464 · see citing works

β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection

Noma, T., Lemaire, A., Prasad, S. V. N., Barki‐Harrington, L., Tilley, D. G., Chen, J., Corvoisier, P. L., Violin, J. D., Wei, H., Lefkowitz, R. J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31901 · Cited by 450 · see citing works

A Model for Arrestin’s Regulation: The 2.8 Å Crystal Structure of Visual Arrestin

Hirsch, J. A., Schubert, C., Gurevich, V. V., & Sigler, P. B. (1999) · Cell · doi:10.1016/s0092-8674(00)80735-7 · Cited by 437 · see citing works

Recent developments in adenosine receptor ligands and their potential as novel drugs

Müller, C. E., & Jacobson, K. A. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.017 · Cited by 431 · see citing works

The β2-Adrenergic Receptor Delivers an Antiapoptotic Signal to Cardiac Myocytes Through Gi-Dependent Coupling to Phosphatidylinositol 3′-Kinase

Chesley, A., Lundberg, M. S., Asai, T., Xiao, R.-P., Ohtani, S., Lakatta, E. G., & Crow, M. T. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1172 · Cited by 422 · see citing works

Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling

Shukla, A. K., Xiao, K., & Lefkowitz, R. J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.06.003 · Cited by 418 · see citing works

Crystal Structure of β-Arrestin at 1.9 Å

Han, M., Gurevich, V. V., Vishnivetskiy, S. A., Sigler, P. B., & Schubert, C. (2001) · Structure · doi:10.1016/s0969-2126(01)00644-x · Cited by 398 · see citing works

Agonist‐selective mechanisms of GPCR desensitization

Kelly, E., Bailey, C. P., & Henderson, G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707604 · Cited by 388 · see citing works

Recounting Cardiac Cellular Composition

Zhou, P., & Pu, W. T. (2016) · Circulation Research · doi:10.1161/circresaha.116.308139 · Cited by 388 · see citing works

Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis

MacKenna, D. A. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00030-4 · Cited by 387 · see citing works

Serotonin 2B receptor is required for heart development

Nebigil, C. G., Choi, D., Dierich, A., Hickel, P., LeMeur, M., Messaddeq, N., Launay, J., & Maroteaux, L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9508 · Cited by 382 · see citing works

Distinct conformations of GPCR–β-arrestin complexes mediate desensitization, signaling, and endocytosis

Cahill, T. J., Thomsen, A. R. B., Tarrasch, J. T., Plouffe, B., Nguyen, A. H., Yang, F., Huang, L.-Y., Kahsai, A. W., Bassoni, D. L., Gavino, B. J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701529114 · Cited by 382 · see citing works

Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling

Paradis, P., Dali‐Youcef, N., Paradis, F. W., Thibault, G., & Nemer, M. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.931 · Cited by 381 · see citing works

GPCR desensitization: Acute and prolonged phases

Rajagopal, S., & Shenoy, S. K. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.01.024 · Cited by 376 · see citing works

Selectively Engaging β-Arrestins at the Angiotensin II Type 1 Receptor Reduces Blood Pressure and Increases Cardiac Performance

Violin, J. D., DeWire, S. M., Yamashita, D. S., Rominger, D. H., Nguyen, L., Schiller, K., Whalen, E. J., Gowen, M., & Lark, M. W. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173005 · Cited by 373 · see citing works

Lack of beta-arrestin signaling in the absence of active G proteins

Grundmann, M., Merten, N., Malfacini, D., Inoue, A., Preis, P., Simon, K., Rüttiger, N., Ziegler, N., Benkel, T., Schmitt, N., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02661-3 · Cited by 361 · see citing works

Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure

McMurray, J. J. V., Teerlink, J. R., Cotter, G., Bourge, R. C., Cleland, J. G. F., Jondeau, G., Krum, H., Metra, M., O’Connor, C. M., Parker, J. D., et al. (2007) · JAMA · doi:10.1001/jama.298.17.2009 · Cited by 357 · see citing works

Coupling ligand structure to specific conformational switches in the β2-adrenoceptor

Yao, X.-J., Parnot, C., Deupí, X., Ratnala, V. R. P., Swaminath, G., Farrens, D., & Kobilka, B. K. (2006) · Nature Chemical Biology · doi:10.1038/nchembio801 · Cited by 353 · see citing works

Single-molecule analysis of ligand efficacy in β2AR–G-protein activation

Gregorio, G. G., Masureel, M., Hilger, D., Terry, D. S., Juette, M. F., Zhao, H. C., Zhou, Z., Perez‐Aguilar, J. M., Hauge, M., Mathiasen, S., et al. (2017) · Nature · doi:10.1038/nature22354 · Cited by 348 · see citing works

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin A Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial

Anand, I. S., McMurray, J. J. V., Cohn, J. N., Konstam, M. A., Notter, T., Quitzau, K., Ruschitzka, F. T., & Lüscher, T. F. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16723-8 · Cited by 346 · see citing works

The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo

Ashley, E. A., Powers, J. C., Chen, M. M., Kundu, R. K., Finsterbach, T., Caffarelli, A. D., Deng, A. C., EICHHORN, J., MAHAJAN, R., & Agrawal, R. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.08.018 · Cited by 345 · see citing works

Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis

Chun, H. J., Ali, Z. A., Kojima, Y., Kundu, R. K., Sheikh, A. Y., Agrawal, R., Zheng, L., Leeper, N. J., Pearl, N., Patterson, A. J., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34871 · Cited by 329 · see citing works

Acute Cardiovascular Effects of Apelin in Humans

Japp, A. G., Cruden, N. L. M., Barnes, G. D., van Gemeren, N., Mathews, J. A., Adamson, J., Johnston, N. R., Denvir, M. A., Megson, I. L., Flapan, A. D., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.911339 · Cited by 328 · see citing works

HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P 1 to limit vascular inflammation

Galvani, S., Sanson, M., Blaho, V. A., Swendeman, S. L., Obinata, H., Conger, H., Dahlbäck, B., Kono, M., Proia, R. L., Smith, J. D., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aaa2581 · Cited by 317 · see citing works

Angiotensin II Partly Mediates Mechanical Stress–Induced Cardiac Hypertrophy

Yamazaki, T., Komuro, I., Kudoh, S., Zou, Y., Shiojima, I., Mizuno, T., Takano, H., Hiroi, Y., Ueki, K., Tobe, K., et al. (1995) · Circulation Research · doi:10.1161/01.res.77.2.258 · Cited by 304 · see citing works

5-Hydroxytryptamine receptors in the human cardiovascular system

Kaumann, A. J., & Levy, F. O. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.12.004 · Cited by 304 · see citing works

Contrasting Actions of Endothelin ETAand ETBReceptors in Cardiovascular Disease

Schneider, M. P., Boesen, E. I., & Pollock, D. M. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105134 · Cited by 292 · see citing works

Effects of endothelins on collagen turnover in cardiac fibroblasts

Eduardo Guarda, S., Katwa, L. C., Myers, P. R., Tyagi, S. C., & Weber, K. T. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2130 · Cited by 291 · see citing works

Relaxin Modulates Cardiac Fibroblast Proliferation, Differentiation, and Collagen Production and Reverses Cardiac Fibrosis in Vivo

Samuel, C. S., Unemori, E., Mookerjee, I., Bathgate, R. A. D., Layfield, S. L., Mak, J. Y., Tregear, G. W., & Du, X. (2004) · Endocrinology · doi:10.1210/en.2004-0209 · Cited by 288 · see citing works

Endogenous Endothelin-1 Participates in the Maintenance of Cardiac Function in Rats With Congestive Heart Failure

Sakai, S., Miyauchi, T., Sakurai, T., Kasuya, Y., Ihara, M., Yamaguchi, I., Goto, K., & Sugishita, Y. (1996) · Circulation · doi:10.1161/01.cir.93.6.1214 · Cited by 285 · see citing works

Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure

Kukin, M. L., Kalman, J., Charney, R. H., Levy, D. K., Buchholz-Varley, C., Ocampo, O. N., & Eng, C. (1999) · Circulation · doi:10.1161/01.cir.99.20.2645 · Cited by 285 · see citing works

Increased endothelin in experimental heart failure.

Margulies, K. B., Hildebrand, F. L., Lerman, A., Perrella, M. A., & Burnett, J. C. J. (1990) · Circulation · doi:10.1161/01.cir.82.6.2226 · Cited by 284 · see citing works

β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation

Kim, I., Tilley, D. G., Chen, J., Salazar, N. C., Whalen, E. J., Violin, J. D., & Rockman, H. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804745105 · Cited by 276 · see citing works

Changes in membrane currents in bullfrog atrium produced by acetylcholine.

Giles, W. R., & Noble, S. J. (1976) · The Journal of Physiology · doi:10.1113/jphysiol.1976.sp011550 · Cited by 256 · see citing works

β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα

Witherow, D. S., Garrison, T. R., Miller, W. E., & Lefkowitz, R. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402851101 · Cited by 254 · see citing works

Adenosine Receptors and the Heart: Role in Regulation of Coronary Blood Flow and Cardiac Electrophysiology

Mustafa, S. J., Morrison, R. R., Teng, B., & Pelleg, A. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-89615-9_6 · Cited by 253 · see citing works

Multiple ligand-specific conformations of the β2-adrenergic receptor

Kahsai, A. W., Xiao, K., Rajagopal, S., Ahn, S., Shukla, A. K., Sun, J., Oas, T. G., & Lefkowitz, R. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.634 · Cited by 250 · see citing works

Recent Advances in Cardiac β2-Adrenergic Signal Transduction

Xiao, R., Cheng, H., Zhou, Y., Kuschel, M., & Lakatta, E. G. (1999) · Circulation Research · doi:10.1161/01.res.85.11.1092 · Cited by 244 · see citing works

β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice

Walters, R. W., Shukla, A. K., Kovacs, J. J., Violin, J. D., DeWire, S. M., Lam, C. M., Chen, J. R., Muehlbauer, M. J., Whalen, E. J., & Lefkowitz, R. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36806 · Cited by 240 · see citing works

Sphingosine-1-phosphate receptor signalling in the heart

Means, C. K., & Brown, J. H. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp086 · Cited by 238 · see citing works

Diuretic Versus α-Blocker as First-Step Antihypertensive Therapy

(2003) · Hypertension · doi:10.1161/01.hyp.0000086521.95630.5a · Cited by 236 · see citing works

Significance of Ventricular Myocytes and Nonmyocytes Interaction During Cardiocyte Hypertrophy

Harada, M., Itoh, H., Nakagawa, O., Ogawa, Y., Miyamoto, Y., Kuwahara, K., Ogawa, E., Igaki, T., Yamashita, J. K., Masuda, I., et al. (1997) · Circulation · doi:10.1161/01.cir.96.10.3737 · Cited by 235 · see citing works

Essential Role of Smad3 in Angiotensin II–Induced Vascular Fibrosis

Wang, W., Huang, X. R., Canlas, E., Oka, K., Truong, L. D., Deng, C., Bhowmick, N. A., Ju, W., Böttinger, E. P., & Lan, H. Y. (2006) · Circulation Research · doi:10.1161/01.res.0000218782.52610.dc · Cited by 234 · see citing works

Nebivolol: A Third-Generation β-Blocker That Augments Vascular Nitric Oxide Release

Broeders, M. A. W., Doevendans, P. A., Bekkers, B. C. A. M., Bronsaer, R., van Gorsel, E., Heemskerk, J. W. M., Egbrink, M. G. A. O., van Breda, E., Reneman, R. S., & van der Zee, R. (2000) · Circulation · doi:10.1161/01.cir.102.6.677 · Cited by 219 · see citing works

Catalytic activation of β-arrestin by GPCRs

Eichel, K., Jullié, D., Barsi‐Rhyne, B., Latorraca, N. R., Masureel, M., Sibarita, J., Dror, R. O., & von Zastrow, M. (2018) · Nature · doi:10.1038/s41586-018-0079-1 · Cited by 217 · see citing works

Endothelin Receptor Blockers in Cardiovascular Disease

Rich, S., & McLaughlin, V. V. (2003) · Circulation · doi:10.1161/01.cir.0000094397.19932.78 · Cited by 213 · see citing works

Angiotensin II Activates Programmed Myocyte Cell Deathin Vitro

Cigola, E., Kajstura, J., Li, B., Meggs, L. G., & Anversa, P. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3477 · Cited by 209 · see citing works

Cardiac GPCRs: GPCR signaling in healthy and failing hearts

Salazar, N. C., Chen, J., & Rockman, H. A. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.010 · Cited by 207 · see citing works

Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice.

Devic, E., Xiang, Y. K., Gould, D. J., & Kobilka, B. K. (2001) · PubMed · Cited by 206 · see citing works

Manifold roles of β-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9

Luttrell, L. M., Wang, J., Plouffe, B., Smith, J. S., Yamani, L., Kaur, S., Jean‐Charles, P., Gauthier, C., Lee, M., Pani, B., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aat7650 · Cited by 206 · see citing works

Cardiac Alpha1-Adrenergic Receptors: Novel Aspects of Expression, Signaling Mechanisms, Physiologic Function, and Clinical Importance

O’Connell, T. D., Jensen, B. C., Baker, A. J., & Simpson, P. C. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007203 · Cited by 205 · see citing works

The α1A/C- and α1B-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse

O’Connell, T. D., Ishizaka, S., Nakamura, A., Swigart, P. M., Rodrigo, M. C., Simpson, G. L., Cotecchia, S., Rokosh, G. D., Grossman, W., Foster, E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16100 · Cited by 205 · see citing works

Mechanism of intracellular allosteric β2AR antagonist revealed by X-ray crystal structure

Liu, X., Ahn, S., Kahsai, A. W., Meng, K.-C., Latorraca, N. R., Pani, B., Venkatakrishnan, A., Masoudi, A., Weis, W. I., Dror, R. O., et al. (2017) · Nature · doi:10.1038/nature23652 · Cited by 203 · see citing works

Genetic evidence that β-arrestins are dispensable for the initiation of β 2 -adrenergic receptor signaling to ERK

O’Hayre, M., Eichel, K., Avino, S., Zhao, X., Steffen, D. J., Feng, X., Kawakami, K., Aoki, J., Messer, K. S., Sunahara, R. K., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aal3395 · Cited by 200 · see citing works

Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy

Rahmeh, R., Damian, M., Cottet, M., Orcel, H., Mendre, C., Durroux, T., Sharma, K. S., Durand, G., Pucci, B., Trinquet, E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201093109 · Cited by 196 · see citing works

β-Arrestin–Biased Agonism of the Angiotensin Receptor Induced by Mechanical Stress

Rakesh, K., Yoo, B., Kim, I., Salazar, N. C., Kim, K.-S., & Rockman, H. A. (2010) · Science Signaling · doi:10.1126/scisignal.2000769 · Cited by 187 · see citing works

Pharmacology of adenosine receptors in the vasculature

Tabrizchi, R., & Bedi, S. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00152-8 · Cited by 187 · see citing works

Conformational switch of angiotensin II type 1 receptor underlying mechanical stress‐induced activation

Yasuda, N., Miura, S., Akazawa, H., Tanaka, T., Qin, Y., Kiya, Y., Imaizumi, S., Fujino, M., Ito, K., Zou, Y., et al. (2008) · EMBO Reports · doi:10.1038/sj.embor.7401157 · Cited by 184 · see citing works

Cardiovascular endothelins: Essential regulators of cardiovascular homeostasis

Brünner, F., Brás‐Silva, C., Cerdeira, A. S., & Leite-Moreira, A. F. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.001 · Cited by 181 · see citing works

Feedback Inhibition of Catecholamine Release by Two Different α 2 -Adrenoceptor Subtypes Prevents Progression of Heart Failure

Brede, M., Wiesmann, F., Jahns, R., Hadamek, K., Arnolt, C., Neubauer, S., Lohse, M. J., & Hein, L. (2002) · Circulation · doi:10.1161/01.cir.0000036600.39600.66 · Cited by 180 · see citing works

Involvement of Rho-Kinase in Angiotensin II–Induced Hypertrophy of Rat Vascular Smooth Muscle Cells

Yamakawa, T., Tanaka, S., Numaguchi, K., Yamakawa, Y., Motley, E. D., Ichihara, S., & Inagami, T. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.313 · Cited by 178 · see citing works

Angiotensin II–Induced Cardiac Hypertrophy and Hypertension Are Attenuated by Epidermal Growth Factor Receptor Antisense

Kagiyama, S., Eguchi, S., Frank, G. D., Inagami, T., Zhang, Y. C., & Phillips, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000030181.63741.56 · Cited by 177 · see citing works

Ischemic Neoangiogenesis Enhanced by β2-Adrenergic Receptor Overexpression

Iaccarino, G., Ciccarelli, M., Sorriento, D., Galasso, G., Campanile, A., Santulli, G., Cipolletta, E., Cerullo, V., Cimini, V., Altobelli, G. G., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000191541.06788.bb · Cited by 176 · see citing works

Muscarinic regulation of cardiac ion channels

Harvey, R. D., & Belevych, A. E. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705338 · Cited by 175 · see citing works

Role of Endothelin-1 in Clinical Hypertension

Dhaun, N., Goddard, J. G., Kohan, D. E., Pollock, D. M., Schiffrin, E. L., & Webb, D. J. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.117366 · Cited by 173 · see citing works

Cardiac-specific overexpression of AT1 receptor mutant lacking G q/G i coupling causes hypertrophy and bradycardia in transgenic mice

Zhai, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25330 · Cited by 171 · see citing works

Acute adenosinergic cardioprotection in ischemic-reperfused hearts.

Headrick, J. P., Hack, B., & Ashton, K. J. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00407.2003 · Cited by 171 · see citing works

Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System

Forrester, S. J., Kawai, T., O’Brien, S. L., Thomas, W. G., Harris, R. C., & Eguchi, S. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-070115-095427 · Cited by 170 · see citing works

β-Adrenergic receptor subtype signaling in heart: From bench to bedside

Woo, A. Y., & Xiao, R. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.201 · Cited by 168 · see citing works

Cardiorenal Actions of TRV120027, a Novel ß-Arrestin–Biased Ligand at the Angiotensin II Type I Receptor, in Healthy and Heart Failure Canines

Boerrigter, G., Lark, M. W., Whalen, E. J., Soergel, D. G., Violin, J. D., & Burnett, J. C. J. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.962571 · Cited by 168 · see citing works

Aldosterone and Angiotensin II Synergistically Stimulate Migration in Vascular Smooth Muscle Cells Through c-Src-Regulated Redox-Sensitive RhoA Pathways

Montezano, A. C. I., Callera, G. E., Yogi, Á., He, Y., Tostes, R. C., He, G., Schiffrin, E. L., & Touyz, R. M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.168021 · Cited by 166 · see citing works

ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice

Rockman, H. A., Wachhorst, S. P., Mao, L., & Ross, J. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.6.h2468 · Cited by 160 · see citing works

Identification of Orthosteric and Allosteric Site Mutations in M2 Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling Bias

Gregory, K. J., Hall, N. E., Tobin, A. B., Sexton, P. M., & Christopoulos, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094011 · Cited by 159 · see citing works

Differential Control of Adrenal and Sympathetic Catecholamine Release by α2-Adrenoceptor Subtypes

Brede, M., Nagy, G., Philipp, M., Sørensen, J. B., Lohse, M. J., & Hein, L. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0035 · Cited by 159 · see citing works

β-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation

Ahn, S., Kim, J., Hara, M. R., Ren, X.-R., & Lefkowitz, R. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808463200 · Cited by 154 · see citing works

The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias

Welihinda, A. A., Kaur, M., Greene, K., Zhai, Y., & Amento, E. P. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.02.010 · Cited by 152 · see citing works

Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system

Yang, P. B., Maguire, J. J., & Davenport, A. P. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.06.002 · Cited by 150 · see citing works

Targeting of Diacylglycerol Degradation to M1 Muscarinic Receptors by ß-Arrestins

Nelson, C. D., Perry, S. J., Regier, D. S., Prescott, S. M., Topham, M. K., & Lefkowitz, R. J. (2007) · Science · doi:10.1126/science.1134562 · Cited by 150 · see citing works

Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)

Pang, P. S., Butler, J., Collins, S. P., Cotter, G., Davison, B. A., Ezekowitz, J. A., Filippatos, G. S., Levy, P. D., Metra, M., Ponikowski, P. P., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx196 · Cited by 149 · see citing works

Functional beta-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes.

Boivin, B., Lavoie, C., Vaniotis, G., Baragli, A., Villeneuve, L., Éthier, N., Trieu, P., Allen, B., & Hébert, T. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.03.015 · Cited by 147 · see citing works

Overexpression of the Serotonin 5-HT 2B Receptor in Heart Leads to Abnormal Mitochondrial Function and Cardiac Hypertrophy

Nebigil, C. G., Jaffré, F., Messaddeq, N., Hickel, P., Monassier, L., Launay, J., & Maroteaux, L. (2003) · Circulation · doi:10.1161/01.cir.0000074224.57016.01 · Cited by 144 · see citing works

Central Role of the MAPK Pathway in Ang II–Mediated DNA Synthesis and Migration in Rat Vascular Smooth Muscle Cells

Xi, X.-P., Graf, K., Goetze, S., Fleck, E., Hsueh, W. A., & Law, R. E. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.1.73 · Cited by 142 · see citing works

1-Adrenergic receptors prevent a maladaptive cardiac response to pressure overload

O’Connell, T. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci22811 · Cited by 141 · see citing works

Functional Endothelin Receptors Are Present on Nuclei in Cardiac Ventricular Myocytes

Boivin, B., Chevalier, D., Villeneuve, L. R., Rousseau, É., & Allen, B. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301738200 · Cited by 138 · see citing works

Gα12/13- and Reactive Oxygen Species-dependent Activation of c-Jun NH2-terminal Kinase and p38 Mitogen-activated Protein Kinase by Angiotensin Receptor Stimulation in Rat Neonatal Cardiomyocytes

Nishida, M., Tanabe, S., Maruyama, Y., Mangmool, S., Urayama, K., Nagamatsu, Y., Takagahara, S., Turner, J. H., Kozasa, T., Kobayashi, H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409710200 · Cited by 138 · see citing works

β-Adrenergic Receptor-mediated DNA Synthesis in Cardiac Fibroblasts Is Dependent on Transactivation of the Epidermal Growth Factor Receptor and Subsequent Activation of Extracellular Signal-regulated Kinases

Kim, J., Eckhart, A. D., Eguchi, S., & Koch, W. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204895200 · Cited by 137 · see citing works

Beta2-adrenergic receptor regulates cardiac fibroblast autophagy and collagen degradation

Aránguiz, P., Canales, J., Copaja, M., Troncoso, R., Vicencio, J. M., Carrillo, C., Lara, H., Lavandero, S., & Dı́az-Araya, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.003 · Cited by 137 · see citing works

Bisoprolol dose–response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study (CIBIS II)

Simon, T. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00743-1 · Cited by 136 · see citing works

Vascular smooth muscle cell durotaxis depends on extracellular matrix composition

Hartman, C. D., Isenberg, B. C., Chua, S. G., & Wong, J. Y. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611324113 · Cited by 136 · see citing works

Clinical Adverse Effects of Endothelin Receptor Antagonists: Insights From the Meta‐Analysis of 4894 Patients From 24 Randomized Double‐Blind Placebo‐Controlled Clinical Trials

Wei, A., Gu, Z., Li, J., Liu, X., Wu, X., Han, Y., & Pu, J. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003896 · Cited by 136 · see citing works

Involvement of the Serotonin 5-HT 2B Receptor in Cardiac Hypertrophy Linked to Sympathetic Stimulation

Jaffré, F., Callebert, J., Sarre, A., Étienne-Selloum, N., Nebigil, C. G., Launay, J., Maroteaux, L., & Monassier, L. (2004) · Circulation · doi:10.1161/01.cir.0000139856.20505.57 · Cited by 133 · see citing works

Angiotensin II-mediated Growth and Antigrowth Effects in Cultured Neonatal Rat Cardiac Myocytes and Fibroblasts

van Kesteren, C. A. M., Heugten, H. A. A. V., Lamers, J. M. J., Saxena, P. R., Schalekamp, M. A. D. H., & Danser, A. H. J. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0448 · Cited by 132 · see citing works

Role of Angiotensin II–Regulated Apoptosis Through Distinct AT 1 and AT 2 Receptors in Neointimal Formation

Suzuki, J., Iwai, M., Hironori Nakagami, A., Wu, L., Chen, R., Sugaya, T., Hamada, M., Hiwada, K., & Horiuchi, M. (2002) · Circulation · doi:10.1161/01.cir.0000024103.04821.86 · Cited by 130 · see citing works

Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands

Gurwitz, D., Haring, R., Heldman, E., Fraser, C. M., Manor, D., & Fisher, A. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90220-8 · Cited by 129 · see citing works

Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure

Brodde, O. ‐., Michel, M. C., & Zerkowski, H.-R. (1995) · Cardiovascular Research · doi:10.1016/s0008-6363(95)00152-2 · Cited by 129 · see citing works

Temporal Dispersion of Activation of Phospholipase C-β1 and -γ Isoforms by Angiotensin II in Vascular Smooth Muscle Cells

Ushio‐Fukai, M., Griendling, K. K., Akers, M., Lyons, P. R., & Alexander, R. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.31.19772 · Cited by 124 · see citing works

β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury

Kim, K.-S., Abraham, D., Williams, B. Y., Violin, J. D., Mao, L., & Rockman, H. A. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00475.2012 · Cited by 122 · see citing works

Nuclear α1-Adrenergic Receptors Signal Activated ERK Localization to Caveolae in Adult Cardiac Myocytes

Wright, C. D., Chen, Q., Baye, N. L., Huang, Y., Healy, C. L., Kasinathan, S., & O’Connell, T. D. (2008) · Circulation Research · doi:10.1161/circresaha.108.176024 · Cited by 120 · see citing works

Inhibiting Insulin-Mediated β 2 -Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction

Wang, Q., Liu, Y., Fu, Q., Xu, B. Y., Zhang, Y., Kim, S., Tan, R., Barbagallo, F., West, T. M., Anderson, E. J., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022281 · Cited by 117 · see citing works

AMP-activated Protein Kinase Phosphorylates and Desensitizes Smooth Muscle Myosin Light Chain Kinase

Horman, S., Morel, N., Vertommen, D., Hussain, N., Neumann, D., Beauloye, C., Najjar, N. E., Forcet, C., Viollet, B., Walsh, M. P., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802053200 · Cited by 116 · see citing works

Angiotensin‐(1‐7): Pharmacology and New Perspectives in Cardiovascular Treatments

Trask, A. J., & Ferrario, C. M. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00012.x · Cited by 114 · see citing works

Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction

Ainscough, J., Drinkhill, M. J., Sedó, A., Turner, N. A., Brooke, D., Balmforth, A. J., & Ball, S. G. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn230 · Cited by 114 · see citing works

The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium

Ray, C. J., & Marshall, J. M. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.099390 · Cited by 113 · see citing works

Independent β-Arrestin2 and Gq/Protein Kinase Cζ Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor

Kim, J., Ahn, S., Rajagopal, K., & Lefkowitz, R. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808176200 · Cited by 111 · see citing works

Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy

Teixeira, L. B., Parreiras‐e‐Silva, L. T., Bruder-Nascimento, T. B., Duarte, D. Â., Simões, S. C., da Costa, R. M., Rodríguez-Sarmiento, D. Y., Ferreira, P., Silva, C. A. A., Abrão, E. P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12074-3 · Cited by 110 · see citing works

β1-Adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction

Yoo, B., Lemaire, A., Mangmool, S., Wolf, M. J., Curcio, A., Mao, L., & Rockman, H. A. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00504.2009 · Cited by 108 · see citing works

ANG II promotes IGF-IIR expression and cardiomyocyte apoptosis by inhibiting HSF1 via JNK activation and SIRT1 degradation

Huang, C.-Y., Kuo, W.-W., Yeh, Y.-L., Ho, T.-J., Lin, J.-Y., Dy, L., Chu, C.-H., Tsai, F.-J., Tsai, C.-H., & Huang, C.-Y. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.46 · Cited by 107 · see citing works

Angiotensin II-Induced Extracellular Signal-Regulated Kinase 1/2 Activation Is Mediated by Protein Kinase Cδ and Intracellular Calcium in Adult Rat Cardiac Fibroblasts

Olson, E. R., Shamhart, P. E., Naugle, J. E., & Meszaros, J. G. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.098459 · Cited by 107 · see citing works

Impact of Blockade of Histamine H2Receptors on Chronic Heart Failure Revealed by Retrospective and Prospective Randomized Studies

Kim, J., Ogai, A., Nakatani, S., Hashimura, K., Kanzaki, H., Komamura, K., Asakura, M., Asanuma, H., Kitamura, S., Tomoike, H., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.069 · Cited by 106 · see citing works

Src Is an Important Mediator of Extracellular Signal–Regulated Kinase 1/2–Dependent Growth Signaling by Angiotensin II in Smooth Muscle Cells From Resistance Arteries of Hypertensive Patients

Touyz, R. M., He, G., Wu, X., Park, J. B., Mabrouk, M. E., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/01.hyp.38.1.56 · Cited by 105 · see citing works

Gαi is required for carvedilol-induced β1 adrenergic receptor β-arrestin biased signaling

Wang, J., Hanada, K., Staus, D. P., Makara, M. A., Dahal, G. R., Chen, Q., Ahles, A., Engelhardt, S. H., & Rockman, H. A. (2017) · Nature Communications · doi:10.1038/s41467-017-01855-z · Cited by 105 · see citing works

β-Arrestin Mediates β1-Adrenergic Receptor-Epidermal Growth Factor Receptor Interaction and Downstream Signaling

Tilley, D. G., Kim, I., Patel, P. A., Violin, J. D., & Rockman, H. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.005793 · Cited by 103 · see citing works

Cloning of the rat alpha 1C-adrenergic receptor from cardiac myocytes. alpha 1C, alpha 1B, and alpha 1D mRNAs are present in cardiac myocytes but not in cardiac fibroblasts.

Stewart, A. F. R., Rokosh, G. D., Bailey, B. A., Karns, L. R., Chang, K. C., Long, C. S., Kariya, K. M., & Simpson, P. C. (1994) · Circulation Research · doi:10.1161/01.res.75.4.796 · Cited by 99 · see citing works

β-Arrestin-mediated Signaling Regulates Protein Synthesis

DeWire, S. M., Kim, J., Whalen, E. J., Ahn, S., Chen, M., & Lefkowitz, R. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710515200 · Cited by 98 · see citing works

Adenosine as an Antiarrhythmic Agent

Wilbur, S. L., & Marchlinski, F. E. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00261-0 · Cited by 98 · see citing works

Serotonin Increases Interleukin-6 Synthesis in Human Vascular Smooth Muscle Cells

Ito, T., Ikeda, U., Shimpo, M., Yamamoto, K., & Shimada, K. (2000) · Circulation · doi:10.1161/01.cir.102.20.2522 · Cited by 97 · see citing works

Biased G Protein–Coupled Receptor Signaling

Wisler, J. W., Rockman, H. A., & Lefkowitz, R. J. (2018) · Circulation · doi:10.1161/circulationaha.117.028194 · Cited by 96 · see citing works

Global analysis of G‐protein‐coupled receptor signaling in human tissues

Hakak, Y., Shrestha, D., Goegel, M. C., Behan, D. P., & Chalmers, D. T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00762-2 · Cited by 92 · see citing works

X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog

Shihoya, W., Nishizawa, T., Yamashita, K., Inoue, A., Hirata, K., Kadji, F. M. N., Okuta, A., Tani, K., Aoki, J., Fujiyoshi, Y., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3450 · Cited by 91 · see citing works

Increased Myocardial Muscarinic Receptor Density in Idiopathic Dilated Cardiomyopathy

Guludec, D. L., Solal, A. C., Delforge, J., Delahaye, N., Syrota, A., & Merlet, P. (1997) · Circulation · doi:10.1161/01.cir.96.10.3416 · Cited by 90 · see citing works

Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts

Haag, S., Matthiesen, S., Juergens, U. R., & Racké, K. (2008) · European Respiratory Journal · doi:10.1183/09031936.00129307 · Cited by 90 · see citing works

Functional Identification of Histamine H3-Receptors in the Human Heart

Imamura, M., Seyedi, N., Lander, H. M., & Levi, R. (1995) · Circulation Research · doi:10.1161/01.res.77.1.206 · Cited by 89 · see citing works

Long-Term Biased β-Arrestin Signaling Improves Cardiac Structure and Function in Dilated Cardiomyopathy

Ryba, D. M., Li, J., Cowan, C. L., Russell, B., Wolska, B. M., & Solaro, R. J. (2017) · Circulation · doi:10.1161/circulationaha.116.024482 · Cited by 88 · see citing works

Small-Molecule Positive Allosteric Modulators of the β2-Adrenoceptor Isolated from DNA-Encoded Libraries

Ahn, S., Pani, B., Kahsai, A. W., Olsen, E. K., Husemoen, G., Vestergaard, M., Jin, L., Zhao, S., Wingler, L. M., Rambarat, P. K., et al. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.111948 · Cited by 87 · see citing works

Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor

Felker, G. M., Butler, J., Collins, S. P., Cotter, G., Davison, B. A., Ezekowitz, J. A., Filippatos, G. S., Levy, P. D., Metra, M., Ponikowski, P. P., et al. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2014.09.008 · Cited by 85 · see citing works

Phosphodiesterases coordinate cAMP propagation induced by two stimulatory G protein-coupled receptors in hearts

Liu, S., Li, Y., Kim, S., Fu, Q., Parikh, D., Sridhar, B., Shi, Q., Zhang, X., Guan, Y., Chen, X., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117862109 · Cited by 81 · see citing works

The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium

Monasky, M. M., Taglieri, D. M., Henze, M., Warren, C. M., Utter, M. S., Soergel, D. G., Violin, J. D., & Solaro, R. J. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00327.2013 · Cited by 79 · see citing works

A Contemporary View on Endothelial Function in Heart Failure

Shantsila, E., Wrigley, B., Blann, A. D., Gill, P. S., & Lip, G. Y. H. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs066 · Cited by 77 · see citing works

Acetylcholine induces intracellular Ca2+ oscillations and nitric oxide release in mouse brain endothelial cells

Zuccolo, E., Lim, D., Kheder, D. A., Perna, A., Catarsi, P., Botta, L., Rosti, V., Riboni, L., Sancini, G., Tanzi, F., et al. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.06.003 · Cited by 75 · see citing works

The Alpha-1D Is the Predominant Alpha-1-Adrenergic Receptor Subtype in Human Epicardial Coronary Arteries

Jensen, B. C., Swigart, P. M., Laden, M.-E., DeMarco, T., Hoopes, C. W., & Simpson, P. C. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.056 · Cited by 73 · see citing works

Allosteric Modulation of β-Arrestin-biased Angiotensin II Type 1 Receptor Signaling by Membrane Stretch

Tang, W., Strachan, R. T., Lefkowitz, R. J., & Rockman, H. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.585067 · Cited by 70 · see citing works

β-Arrestin1–Biased β 1 -Adrenergic Receptor Signaling Regulates MicroRNA Processing

Kim, I., Wang, Y., Park, K., Tang, Y., Teoh, J., Vinson, J., Traynham, C. J., Pironti, G., Mao, L., Su, H., et al. (2013) · Circulation Research · doi:10.1161/circresaha.114.302766 · Cited by 70 · see citing works

β 2 -Adrenergic Receptor Gene Delivery to the Endothelium Corrects Impaired Adrenergic Vasorelaxation in Hypertension

Iaccarino, G., Cipolletta, E., Fiorillo, A., Annecchiarico, M. M., Ciccarelli, M., Cimini, V., Koch, W. J., & Trimarco, B. (2002) · Circulation · doi:10.1161/01.cir.0000022690.55143.56 · Cited by 67 · see citing works

Adenosine and cardioprotection during reperfusion – an overview

Donato, M., & Gelpi, R. J. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1025454504577 · Cited by 65 · see citing works

Adenosine receptors and second messenger signaling pathways in rat cardiac fibroblasts

Epperson, S. A., Brunton, L. L., Ramírez‐Sánchez, I., & Villarreal, F. J. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00290.2008 · Cited by 65 · see citing works

Intrinsic A1adenosine receptor activation during ischemia or reperfusion improves recovery in mouse hearts

Peart, J. N., & Headrick, J. P. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.5.h2166 · Cited by 64 · see citing works

Smooth muscle cells and vascular diseases

Michel, J., Li, Z., & Lacolley, P. J. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs172 · Cited by 63 · see citing works

Sphingosine‐1‐Phosphate Receptor 1 Regulates Cardiac Function by Modulating Ca 2+ Sensitivity and Na + /H + Exchange and Mediates Protection by Ischemic Preconditioning

Keul, P., van Borren, M. M. G. J., Ghanem, A., Müller, F. U., Baartscheer, A., Verkerk, A. O., Stümpel, F. T., Schulte, J. S., Hamdani, N., Linke, W. A., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003393 · Cited by 63 · see citing works

Disruption of histamine H2 receptor slows heart failure progression through reducing myocardial apoptosis and fibrosis

Zeng, Z., Shen, L., Li, X., Luo, T., Wei, X., Zhang, J., Cao, S., Huang, X., Fukushima, Y., Bin, J., et al. (2014) · Clinical Science · doi:10.1042/cs20130716 · Cited by 61 · see citing works

Partial adenosine A1 receptor agonism: a potential new therapeutic strategy for heart failure

Greene, S. J., Sabbah, H. N., Butler, J., Voors, A. A., Albrecht-Küpper, B. E., Düngen, H., Dinh, W., & Gheorghiade, M. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9522-7 · Cited by 58 · see citing works

Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6

Ohkura, S.-I., Usui, S., Takashima, S., Takuwa, N., Yoshioka, K., Okamoto, Y., Inagaki, Y., Sugimoto, N., Kitano, T., Takamura, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182329 · Cited by 58 · see citing works

Gut microbiota and cardiovascular disease.

Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051 · see citing works

G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery

Zhang, M., Chen, T., Lu, X., Lan, X., Chen, K., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 520 · see citing works

G Protein-Coupled Receptors: A Century of Research and Discovery

Liu, S., Anderson, P. J., Rajagopal, S., Lefkowitz, R. J., & Rockman, H. A. (2024) · Circulation Research · doi:10.1161/circresaha.124.323067 · Cited by 183 · see citing works

Cardiac Fibrosis and Fibroblasts

Kurose, H. (2021) · Cells · doi:10.3390/cells10071716 · Cited by 172 · see citing works

A Global Map of G Protein Signaling Regulation by RGS Proteins

Masuho, I., Santhanam, B., Muntean, B. S., Skamangas, N. K., Chavali, S., Tesmer, J. J. G., Babu, M. M., & Martemyanov, K. A. (2020) · Cell · doi:10.1016/j.cell.2020.08.052 · Cited by 162 · see citing works

Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?

Ballante, F., Kooistra, A. J., Kampen, S., de Graaf, C., & Carlsson, J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000246 · Cited by 160 · see citing works

GPR41 and GPR43: From development to metabolic regulation

Lee, D., Kim, M.-T., & Han, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116735 · Cited by 168 · see citing works

Physiological and pathological roles of protein kinase A in the heart

Liu, Y., Chen, J., Fontes, S. K., Bautista, E. N., & Cheng, Z. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab008 · Cited by 156 · see citing works

Calcium Signaling in Cardiomyocyte FunctionPreprint

Gilbert, G., Demydenko, K., Dries, E., Puertas, R. D., Jin, X., Sipido, K. R., & Roderick, H. L. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a035428 · Cited by 140 · see citing works

Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine

Cheng, H., Liu, J., Tan, Y., Feng, W., & Peng, C. Y. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.10.003 · Cited by 137 · see citing works

Golgi localized β1-adrenergic receptors stimulate Golgi PI4P hydrolysis by PLCε to regulate cardiac hypertrophy

Nash, C. A., Wei, W., Irannejad, R., & Smrcka, A. V. (2019) · eLife · doi:10.7554/elife.48167 · Cited by 113 · see citing works

Beta-blockers: Historical Perspective and Mechanisms of Action

Oliver, E., Mayor, F., & D’Ocón, P. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.04.006 · Cited by 100 · see citing works

G protein-coupled receptor signaling: transducers and effectors

Jiang, H., Galtes, D., Wang, J., & Rockman, H. A. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00210.2022 · Cited by 93 · see citing works

Bloqueadores beta: perspectiva histórica y mecanismos de acción

Oliver, E., Mayor, F., & D’Ocón, P. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.02.023 · Cited by 93 · see citing works

Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development

Kricker, J. A., Page, C. P., Gardarsson, F. R., Baldursson, Ó., Guðjónsson, Þ., & Parnham, M. J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000300 · Cited by 92 · see citing works

The Role of Cyclic AMP Signaling in Cardiac Fibrosis

Delaunay, M., Osman, H., Kaiser, S., & Diviani, D. (2019) · Cells · doi:10.3390/cells9010069 · Cited by 88 · see citing works

Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease

Neumann, J., Hofmann, B., Dhein, S., & Gergs, U. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054765 · Cited by 83 · see citing works

EGFR tyrosine kinase activity and Rab GTPases coordinate EGFR trafficking to regulate macrophage activation in sepsis

Zhang, X., Chen, C., Ling, C., Luo, S., Xiong, Z., Liu, X., Liao, C., Xie, P., Liu, Y., Zhang, L., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05370-y · Cited by 77 · see citing works

Role of the microbiota–gut–heart axis between bile acids and cardiovascular disease

Zhang, Z., Lv, T., Wang, X., Wu, M., Zhang, R., Yang, X., Fu, Y., & Liu, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116567 · Cited by 77 · see citing works

Gαs–Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling

Ramms, D. J., Raimondi, F., Arang, N., Herberg, F. W., Taylor, S. S., & Gutkind, J. S. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000269 · Cited by 71 · see citing works

Beta-Blockers and Cancer: Where Are We?

Peixoto, R., Pereira, M. D. L., & Oliveira, M. (2020) · Pharmaceuticals · doi:10.3390/ph13060105 · Cited by 67 · see citing works

Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome

Ma, K., Gao, W., Xu, H., Liang, W., & Ma, G. (2022) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1155/2022/3239057 · Cited by 69 · see citing works

Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy

Cheng, Y., Wang, Y., Yin, R., Xu, Y., Zhang, L., Zhang, Y., Yang, L., & Zhao, D. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1162754 · Cited by 62 · see citing works

Signaling and function of cardiac autonomic nervous system receptors: Insights from the GPCR signalling universe

Lymperopoulos, A., Cora, N., Maning, J., Brill, A. R., & Sizova, A. (2021) · FEBS Journal · doi:10.1111/febs.15771 · Cited by 60 · see citing works

Catecholamine-induced hypertensive crises: current insights and management

Nazari, M. A., HASAN, M. R., Haigney, M. C., Maghsoudi, A., Lenders, J. W. M., Carey, R. M., & Pacák, K. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00256-5 · Cited by 55 · see citing works

A Bitter Taste in Your Heart

Bloxham, C. J., Foster, S. R., & Thomas, W. G. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00431 · Cited by 53 · see citing works

Structure-based design of non-hypertrophic apelin receptor modulator

Wang, W., Ji, S., Zhang, W., Zhang, J., Cai, C., Hu, R., Zang, S., Miao, L., Xu, H., Chen, L.-N., et al. (2024) · Cell · doi:10.1016/j.cell.2024.02.004 · Cited by 51 · see citing works

Emerging Role of Compartmentalized G Protein-Coupled Receptor Signaling in the Cardiovascular Field

Plouffe, B., Thomsen, A. R. B., & Irannejad, R. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00006 · Cited by 46 · see citing works

Gut microbe-generated phenylacetylglutamine is an endogenous allosteric modulator of β2-adrenergic receptors

Saha, P. P., Gogonea, V., Sweet, W. E., Mohan, M. L., Singh, K. D., Anderson, J. T., Mallela, D. P., Witherow, C., Kar, N. S., Stenson, K. T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50855-3 · Cited by 50 · see citing works

Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction

Pinilla-Vera, M., Hahn, V. S., & Kass, D. A. (2019) · Circulation Research · doi:10.1161/circresaha.119.313682 · Cited by 49 · see citing works

Flow-mediated vasodilation through mechanosensitive G protein-coupled receptors in endothelial cells

Hu, Y. W., Chen, M., Wang, M., & Li, X. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.12.010 · Cited by 48 · see citing works

G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment

Yang, M. J., & Zhang, C. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i8.677 · Cited by 49 · see citing works

Structural insights into angiotensin receptor signaling modulation by balanced and biased agonists

Zhang, D., Liu, Y., Zaidi, S. A., Xu, L., Zhan, Y., Chen, A., Guo, J., Huang, X., Roth, B. L., Katritch, V., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022112940 · Cited by 47 · see citing works

Reverse Cardiac Remodeling and ARNI Therapy

Abboud, A., & Januzzi, J. L. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-021-00501-6 · Cited by 47 · see citing works

Expression of hub genes of endothelial cells in glioblastoma-A prognostic model for GBM patients integrating single-cell RNA sequencing and bulk RNA sequencing

Zhao, S., Ji, W., Shen, Y., Fan, Y., Huang, H., Huang, J., Lai, G., Yuan, K., & Cheng, C. (2022) · BMC Cancer · doi:10.1186/s12885-022-10305-z · Cited by 44 · see citing works

β-Arrestin–Biased Allosteric Modulator Potentiates Carvedilol-Stimulated β Adrenergic Receptor Cardioprotection

Wang, J., Pani, B., Gokhan, I., Xiong, X., Kahsai, A. W., Jiang, H., Ahn, S., Lefkowitz, R. J., & Rockman, H. A. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000359 · Cited by 44 · see citing works

Single-cell genomics improves the discovery of risk variants and genes of atrial fibrillation

Selewa, A., Luo, K., Wasney, M., Smith, L. A., Sun, X., Tang, C., Eckart, H., Moskowitz, I. P. G., Basu, A., He, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40505-5 · Cited by 42 · see citing works

Protein Kinase A Is a Master Regulator of Physiological and Pathological Cardiac Hypertrophy

Bai, Y., Zhang, X., Li, Y., Qi, F., Liu, C., Ai, X., Tang, M., Szeto, C. W., Gao, E., Hua, X., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.322729 · Cited by 43 · see citing works

Role of Gut Microbial Metabolites in Cardiovascular Diseases—Current Insights and the Road Ahead

Datta, S., Pasham, S., Sandeep, I. S., Boini, K. M., & Koka, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810208 · Cited by 42 · see citing works

Nitric Oxide and S-Nitrosylation in Cardiac Regulation: G Protein-Coupled Receptor Kinase-2 and β-Arrestins as Targets

Kayki‐Mutlu, G., & Koch, W. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020521 · Cited by 38 · see citing works

Pathophysiology and pharmacology of G protein-coupled receptors in the heart

Grogan, A., Lucero, E. Y., Jiang, H., & Rockman, H. A. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac171 · Cited by 37 · see citing works

Angiotensin Receptors Heterodimerization and Trafficking: How Much Do They Influence Their Biological Function?

Mikusic, N. L. R., Silva, M. G., Pineda, A. M., & Gironacci, M. M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01179 · Cited by 36 · see citing works

Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis

Yeh, C., Chen, Y.-H., Liu, S.-F., Kao, H., Wu, M., Yang, K., & Wu, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228729 · Cited by 36 · see citing works

The gut microbial metabolite phenylacetylglycine protects against cardiac injury caused by ischemia/reperfusion through activating β2AR

Xu, X., Lu, W.-J., Shi, J., Su, Y.-L., Liu, Y.-C., Wang, L., Xiao, C.-X., Chen, C., & Lu, Q. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108720 · Cited by 33 · see citing works

HFrEF subphenotypes based on 4210 repeatedly measured circulating proteins are driven by different biological mechanisms

Petersen, T. B., de Bakker, M., Asselbergs, F. W., Harakaľová, M., Akkerhuis, K. M., Brugts, J. J., van Ramshorst, J., Lumbers, R. T., Ostroff, R. M., Katsikis, P. D., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104655 · Cited by 32 · see citing works

Unraveling allostery within the angiotensin II type 1 receptor for Gα q and β-arrestin coupling

Cao, Y., van der Velden, W. J. C., Namkung, Y., Nivedha, A. K., Cho, A., Sedki, D., Holleran, B. J., Lee, N. H., Leduc, R., Muk, S., et al. (2023) · Science Signaling · doi:10.1126/scisignal.adf2173 · Cited by 30 · see citing works

Antihypertensive Activity of Milk Fermented by Lactiplantibacillus plantarum SR37-3 and SR61-2 in L-NAME-Induced Hypertensive Rats

Yuan, L., Li, Y., Chen, M., Xue, L., Wang, J., Ding, Y., Zhang, J., Wu, S., Ye, Q., Zhang, S., et al. (2022) · Foods · doi:10.3390/foods11152332 · Cited by 30 · see citing works

Exploring the Activation Process of the β2AR-GsComplex

Bai, C., Wang, J., Mondal, D., Du, Y., Ye, R. D., & Warshel, A. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c03696 · Cited by 29 · see citing works

Multiparametric Mechanistic Profiling of Inotropic Drugs in Adult Human Primary Cardiomyocytes

Abi‐Gerges, N., Indersmitten, T., Truong, K., Nguyen, W., Ratchada, P., Nguyen, N., Page, G., Miller, P. E., & Ghetti, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-64657-2 · Cited by 28 · see citing works

Unique Positive Cooperativity Between the β-Arrestin–Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor

Pani, B., Ahn, S., Rambarat, P. K., Vege, S., Kahsai, A. W., Liu, A., Valan, B. N., Staus, D. P., Costa, T., & Lefkowitz, R. J. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000363 · Cited by 27 · see citing works

Role of G-protein coupled receptors in cardiovascular diseases

Li, Y., Li, B., Chen, W., & Wang, Y. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1130312 · Cited by 26 · see citing works

Treatment optimization of beta-blockers in chronic heart failure therapy

Niriayo, Y. L., Asgedom, S. W., Demoz, G. T., & Gidey, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-72836-4 · Cited by 26 · see citing works

Adrenal angiotensin II type 1 receptor biased signaling: The case for “biased” inverse agonism for effective aldosterone suppression

Ferraino, K. E., Cora, N., Pollard, C. M., Sizova, A., Maning, J., & Lymperopoulos, A. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.109967 · Cited by 26 · see citing works

Inhibition of β1-AR/Gαs signaling promotes cardiomyocyte proliferation in juvenile mice through activation of RhoA-YAP axis

Sakabe, M., Thompson, M., Chen, N., Verba, M., Hassan, A., Lu, Q. R., & Xin, M. (2022) · eLife · doi:10.7554/elife.74576 · Cited by 26 · see citing works

Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression

Eddy, K., Eddin, M. N., Fateeva, A., Pompili, S. V. B., Shah, R., Doshi, S., & Chen, S. (2022) · Cells · doi:10.3390/cells11182857 · Cited by 25 · see citing works

β1-adrenergic receptor N-terminal cleavage by ADAM17; the mechanism for redox-dependent downregulation of cardiomyocyte β1-adrenergic receptors

Zhu, J., & Steinberg, S. F. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.01.012 · Cited by 24 · see citing works

MSK-Mediated Phosphorylation of Histone H3 Ser28 Couples MAPK Signalling with Early Gene Induction and Cardiac Hypertrophy

Robinson, E. L., Drawnel, F., Mehdi, S., Archer, C. R., Liu, W., Okkenhaug, H., Alkass, K., Aronsen, J. M., Nagaraju, C. K., Sjaastad, I., et al. (2022) · Cells · doi:10.3390/cells11040604 · Cited by 24 · see citing works

New insights into the molecular mechanisms of SGLT2 inhibitors on ventricular remodeling

Chen, Y., & Peng, D. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110072 · Cited by 25 · see citing works

Oxysterol Sensing Through GPR183 Triggers Endothelial Senescence in Hypertension

Chu, Q., Li, Y., Wu, J., Gao, Y., Xiangyun, G., Li, J., Lv, H., Liu, M., Tang, W., Zhan, P., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.324722 · Cited by 23 · see citing works

Structural insights into GPCR signaling activated by peptide ligands: from molecular mechanism to therapeutic application

Kim, J., Kim, J., Choi, C., Bae, J., & Choi, H. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01497-y · Cited by 25 · see citing works

Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery

Deepak, R. N. V. K., Verma, R. K., Hartono, Y. D., Yew, W. S., & Fan, H. (2021) · Pharmaceuticals · doi:10.3390/ph15010012 · Cited by 23 · see citing works

Control of Gα q signaling dynamics and GPCR cross-talk by GRKs

Xiang, G., Acosta-Ruiz, A., Radoux-Mergault, A., Kristt, M., Kim, J., Moon, J. D., Broichhagen, J., Inoue, A., Lee, F. S., Stoeber, M., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq3363 · Cited by 23 · see citing works

Hypertensive Heart Disease: Mechanisms, Diagnosis and Treatment

Huang, X., Hu, L., Long, Z., Wang, X., Wu, J., & Cai, J. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2503093 · Cited by 22 · see citing works

Platelet proteome changes in dogs with congestive heart failure

LEVENT, P., KOCATÜRK, M., Akgün, E., SARIL, A., Çevik, Ö. D., Baykal, A. T., Tanaka, R., Cerón, J. M. C., & Yılmaz, Z. (2020) · BMC Veterinary Research · doi:10.1186/s12917-020-02692-x · Cited by 22 · see citing works

Mapping Angiotensin II Type 1 Receptor-Biased Signaling Using Proximity Labeling and Proteomics Identifies Diverse Actions of Biased Agonists

Pfeiffer, C. T., Wang, J., Paulo, J. A., Jiang, X., Gygi, S. P., & Rockman, H. A. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00080 · Cited by 22 · see citing works

Role of Diabetes Mellitus in Heart Failure With Preserved Ejection Fraction: A Review Article

Mgbemena, O. N., Zhang, Y., & Velarde, G. (2021) · Cureus · doi:10.7759/cureus.19398 · Cited by 22 · see citing works

The EDN1/EDNRA/β‑arrestin axis promotes colorectal cancer progression by regulating STAT3 phosphorylation

Lee, Y.-J., Jung, E., Choi, J., Hwang, J.-S., Jeong, E.-J., Roh, Y., Ban, H. S., Kim, S., Kim, S., Kim, S., et al. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5461 · Cited by 22 · see citing works

Differential Activation of P-TEFb Complexes in the Development of Cardiomyocyte Hypertrophy following Activation of Distinct G Protein-Coupled Receptors

Martin, R., Sun, Y., MacKinnon, S., Cuccia, L., Pagé, V., Hébert, T. E., & Tanny, J. C. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00048-20 · Cited by 22 · see citing works

CXCR7 ameliorates myocardial infarction as a β-arrestin-biased receptor

Ishizuka, M., Harada, M., Nomura, S., Ko, T., Ikeda, Y., Guo, J., Bujo, S., Yanagisawa‐Murakami, H., Satoh, M., Yamada, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83022-5 · Cited by 22 · see citing works

Gut-Microbiota-Related Metabolite Phenylacetylglutamine and Risk of Incident Coronary Heart Disease Among Women

Heianza, Y., Tiwari, S., Wang, X., Watrous, J. D., Rexrode, K. M., Hu, F. B., Alotaibi, M., Jain, M., Sun, Q., Manson, J. E., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae525 · Cited by 20 · see citing works

The European Research Network on Signal Transduction (ERNEST): Toward a Multidimensional Holistic Understanding of G Protein-Coupled Receptor Signaling

Sommer, M. E., Selent, J., Carlsson, J., de Graaf, C., Gloriam, D. E. I., Keserű, G. M., Kosloff, M., Mordalski, S., Rizk, A., ROSENKILDE, M. M., et al. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00024 · Cited by 21 · see citing works

Progress on the development of Class A GPCR‐biased ligands

Morales, P., Scharf, M. M., Bermúdez, M., Egyed, A., Franco, R., Hansen, O. K., Jagerovic, N., Jakubík, J., Keserű, G. M., Kiss, D. J., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17301 · Cited by 20 · see citing works

Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signaling

Lymperopoulos, A., Borges, J. I., Carbone, A. M., Cora, N., & Sizova, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105943 · Cited by 20 · see citing works

Biased activation of β2-AR/Gi/GRK2 signal pathway attenuated β1-AR sustained activation induced by β1-adrenergic receptor autoantibody

Chen, H., Cao, N., Wang, L., Wu, Y., Wei, H., Li, Y., Zhang, Y., Zhang, S., & Liu, H. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00735-2 · Cited by 20 · see citing works

Role of cAMP in Cardiomyocyte Viability: Beneficial or Detrimental?

Zhang, Y., Chen, S., Luo, L., Greenly, S., Shi, H., Xu, J. J., & Chen, Y. (2023) · Circulation Research · doi:10.1161/circresaha.123.322652 · Cited by 20 · see citing works

Pathophysiology of Angiotensin II-Mediated Hypertension, Cardiac Hypertrophy, and Failure: A Perspective from Macrophages

Carter, K., Shah, E., Waite, J., Rana, D., & Zhao, Z.-Q. (2024) · Cells · doi:10.3390/cells13232001 · Cited by 22 · see citing works

Risk Prediction in Patients With Heart Failure With Preserved Ejection Fraction Using Gene Expression Data and Machine Learning

Zhou, L., Guo, Z., Wang, B., Wu, Y., Li, Z., Yao, H., Fang, R., Yang, H., Cao, H., & Cui, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.652315 · Cited by 20 · see citing works

Super-resolution microscopy to study membrane nanodomains and transport mechanisms in the plasma membrane

Díaz, Y. D. L. M. Z., & Arnspang, E. C. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1455153 · Cited by 20 · see citing works

Potential Therapeutic Exploitation of G Protein-Coupled Receptor 120 (GPR120/FFAR4) Signaling in Obesity-Related Metabolic Disorders

Szukiewicz, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062501 · Cited by 20 · see citing works

Microbiota‐related metabolites fueling the understanding of ischemic heart disease

Fan, Y., Ying, J., Ma, H., & Cui, H. (2023) · iMeta · doi:10.1002/imt2.94 · Cited by 18 · see citing works

Metabolite signaling in the heart

Flam, E. L., & Arany, Z. P. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00270-6 · Cited by 19 · see citing works

The β 3 ‐Adrenergic Receptor: Structure, Physiopathology of Disease, and Emerging Therapeutic Potential

Dongdem, J. T., Etornam, A. E., Beletaa, S., Alidu, I., Kotey, H., & Wezena, C. A. (2024) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/2024/2005589 · Cited by 20 · see citing works

Targeting protein conformations with small molecules to control protein complexes

Zacharioudakis, E., & Gavathiotis, E. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.07.002 · Cited by 18 · see citing works

RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting

Lymperopoulos, A., Borges, J. I., & Stoicovy, R. A. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115904 · Cited by 18 · see citing works

GPR75: an exciting new target in metabolic syndrome and related disorders

Murtaza, B., Asghar, F., & Patoli, D. (2022) · Biochimie · doi:10.1016/j.biochi.2022.01.005 · Cited by 18 · see citing works

Phosphodiesterases: Evolving Concepts and Implications for Human Therapeutics

Kelly, E. D., Ranek, M. J., Zhang, M., Kass, D. A., & Muller, G. K. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-031524-025239 · Cited by 17 · see citing works

Central amygdala angiotensin type 1 receptor (Agtr1) expressing neurons contribute to fear extinction

Yu, Z., Kisner, A., Bhatt, A., Polter, A. M., & Marvar, P. J. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109460 · Cited by 17 · see citing works

The role of β‐adrenergic receptors in the regulation of cardiac tolerance to ischemia/reperfusion. Why do β‐adrenergic receptor agonists and antagonists protect the heart?

Маслов, Л. Н., Naryzhnaya, N. V., Воронков, Н. С., Kurbatov, B. K., Андреевич, Д. И., Ryabov, V. V., Вышлов, Е. В., Васильевич, К. В., Tomilova, E. A., Валерьевна, С. Е., et al. (2024) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12988 · Cited by 17 · see citing works

Insights into cellular signaling from membrane dynamics

Sarkar, P., & Chattopadhyay, A. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108794 · Cited by 17 · see citing works

Comparing the signaling and transcriptome profiling landscapes of human iPSC-derived and primary rat neonatal cardiomyocytes

Bourque, K., Jones-Tabah, J., Pétrin, D., Martin, R., Tanny, J. C., & Hébert, T. E. (2023) · Scientific Reports · doi:10.1038/s41598-023-39525-4 · Cited by 16 · see citing works

Gradual cold acclimation induces cardioprotection without affecting β-adrenergic receptor-mediated adenylyl cyclase signaling

Tibenská, V., Benesova, A., Vebr, P., Liptakova, A., Hejnová, L., Elsnicová, B., Drahota, Z., Hornikova, D., Galatik, F., Kolar, D., et al. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00511.2019 · Cited by 16 · see citing works

Atypical Roles of the Chemokine Receptor ACKR3/CXCR7 in Platelet Pathophysiology

Chatterjee, M. (2022) · Cells · doi:10.3390/cells11020213 · Cited by 16 · see citing works

Epigenetics and Gut Microbiota Crosstalk: A potential Factor in Pathogenesis of Cardiovascular Disorders

Mehta, V., Nagu, P., Inbaraj, B. S., Sharma, M., Parashar, A., & Sridhar, K. (2022) · Bioengineering · doi:10.3390/bioengineering9120798 · Cited by 17 · see citing works

Increased β1-adrenergic receptor antibody confers a vulnerable substrate for atrial fibrillation via mediating Ca2+ mishandling and atrial fibrosis in active immunization rabbit models

Sun, H., Song, J., Li, K., Li, Y., Shang, L., Zhou, Q., Lu, Y., Zong, Y., He, X., Kari, M., et al. (2023) · Clinical Science · doi:10.1042/cs20220654 · Cited by 16 · see citing works

Research development on gut microbiota and vulnerable atherosclerotic plaque

Zheng, S., Liu, Z., Liu, H., Lim, J. Y., Li, D. W. H., Zhang, S., Luo, F., Wang, X., Sun, C., Tang, R., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25186 · Cited by 17 · see citing works

G protein-coupled receptors and traditional Chinese medicine: new thinks for the development of traditional Chinese medicine

Zhang, T., An, W., You, S., Chen, S., & Zhang, S. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00964-4 · Cited by 16 · see citing works

ASC-J9 Blocks Cell Proliferation and Extracellular Matrix Production of Keloid Fibroblasts through Inhibiting STAT3 Signaling

Hong, Y., Wu, C.-H., Lin, Y., Huang, Y.-L., Hung, K., Pai, T., Liu, Y.-T., Chen, T.-C., Chan, H., & Hsu, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105549 · Cited by 16 · see citing works

Carvedilol Selectively Stimulates βArrestin2-Dependent SERCA2a Activity in Cardiomyocytes to Augment Contractility

Maning, J., Desimine, V. L., Pollard, C. M., Ghandour, J., & Lymperopoulos, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911315 · Cited by 16 · see citing works

Coupling to Gq Signaling Is Required for Cardioprotection by an Alpha-1A-Adrenergic Receptor Agonist

Myagmar, B., Ismaili, T., Swigart, P. M., Raghunathan, A., Baker, A. J., Sahdeo, S., Blevitt, J. M., Milla, M. E., & Simpson, P. C. (2019) · Circulation Research · doi:10.1161/circresaha.118.314416 · Cited by 16 · see citing works

G-Protein-Coupled Receptors in the Heart

Martin, M. L., Belmonte, S. L., Ram, R., Kamal, F., & Blaxall, B. C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381510-1.00008-9

Pathophysiology and pharmacology of G protein-coupled receptors in the heart

Grogan, A., Lucero, E. Y., Jiang, H., & Rockman, H. A. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac171 · Cited by 37 · see citing works

Biased Agonism of G Protein-Coupled Receptors: A Potential Therapeutic Strategy of Cardiovascular Diseases

Kim, Y. H., & Oh, S. O. (2016) · Cardiovascular Pharmacology Open Access · doi:10.4172/2329-6607.1000192 · Cited by 5 · see citing works

Cardiac GPCRs: GPCR signaling in healthy and failing hearts

Salazar, N. C., Chen, J., & Rockman, H. A. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.010 · Cited by 207 · see citing works

GPCR signaling and cardiac function

Capote, L., Perez, R. M., & Lymperopoulos, A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.019 · Cited by 137 · see citing works